These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30900173)

  • 1. Monitoring for Epigenetic Modifications at the FMR1 Locus.
    Epsztejn-Litman S; Eiges R
    Methods Mol Biol; 2019; 1942():29-48. PubMed ID: 30900173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
    Sølvsten C; Nielsen AL
    Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.
    Colak D; Zaninovic N; Cohen MS; Rosenwaks Z; Yang WY; Gerhardt J; Disney MD; Jaffrey SR
    Science; 2014 Feb; 343(6174):1002-5. PubMed ID: 24578575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells.
    Avitzour M; Mor-Shaked H; Yanovsky-Dagan S; Aharoni S; Altarescu G; Renbaum P; Eldar-Geva T; Schonberger O; Levy-Lahad E; Epsztejn-Litman S; Eiges R
    Stem Cell Reports; 2014 Nov; 3(5):699-706. PubMed ID: 25418717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion to Normal of
    Tabolacci E; Pietrobono R; Maneri G; Remondini L; Nobile V; Della Monica M; Pomponi MG; Genuardi M; Neri G; Chiurazzi P
    Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32111011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
    Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
    Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
    Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
    Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Methylation, Mechanisms of
    Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
    Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
    Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Molecules Targeting H3K9 Methylation Prevent Silencing of Reactivated
    Kumari D; Sciascia N; Usdin K
    Genes (Basel); 2020 Mar; 11(4):. PubMed ID: 32230785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.
    Genç B; Müller-Hartmann H; Zeschnigk M; Deissler H; Schmitz B; Majewski F; von Gontard A; Doerfler W
    Nucleic Acids Res; 2000 May; 28(10):2141-52. PubMed ID: 10773084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications of the FMR1 gene.
    Tabolacci E; Neri G
    Methods Mol Biol; 2013; 1010():141-53. PubMed ID: 23754224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
    Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
    PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An origin of DNA replication in the promoter region of the human fragile X mental retardation (FMR1) gene.
    Gray SJ; Gerhardt J; Doerfler W; Small LE; Fanning E
    Mol Cell Biol; 2007 Jan; 27(2):426-37. PubMed ID: 17101793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.
    Brouwer JR; Mientjes EJ; Bakker CE; Nieuwenhuizen IM; Severijnen LA; Van der Linde HC; Nelson DL; Oostra BA; Willemsen R
    Exp Cell Res; 2007 Jan; 313(2):244-53. PubMed ID: 17150213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats.
    Loesch DZ; Bui QM; Huggins RM; Mitchell RJ; Hagerman RJ; Tassone F
    J Med Genet; 2007 Mar; 44(3):200-4. PubMed ID: 16905681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.